Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Natco Pharma Ltd

Natco Pharma Ltd share price and stock overview

Natco Pharma Ltd (NSE: NATCOPHARM, BSE: 524816) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE987B01026 and a face value of Rs 2. As of 26 July 2026, it trades at Rs (921.45) with a market capitalisation of Rs 16492.44 crore. Figures are live and subject to change.

Natco Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
921.45 2.90 (0.32%) upARrowC
As on: 26-Jul-2026 , 10:35 AM
Market Cap(₹Cr) 16492.44
Book Value(₹Cr) 477.507017
BSE Code : 524816 NSE Symbol : NATCOPHARM EPS(TTM) : 71.55 ISIN Demat : INE987B01026 P/E(TTM) : 12.87 Face Value(₹) : 2 Div & Yield % : 0.54

Today Market

Stock Performance

Today Market

Today's High

76,210.95

Todday's Low

75,474.43

Open at

75,708.19

Previous Close

76,391.39

Volumes

Avg Price

-331.62

Historical Performance

News

20 Jul 26
NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets
The approved abbreviated new drug application (ANDA) is therapeutically equivalent to the reference listed drug (RLD), Lynparza Tablets, marketed by AstraZeneca Pharmaceuticals, for the indications specified in the approved labelling.
14 Jul 26
Natco Pharma completes acquisition of additional 13.25% stake in Adcock Ingram
Natco Pharma announced the successful completion of its acquisition of an additional 13.
03 Jun 26
NATCO Pharma, Lupin secure USFDA approval for Eribulin Mesylate injection
The approved product is bioequivalent to Halaven Injection, the reference-listed drug (RLD) marketed by Eisai Inc.
30 May 26
Natco Pharma consolidated net profit declines 34.11% in the March 2026 quarter
Net profit of Natco Pharma declined 34.11% to Rs 267.90 crore in the quarter ended March 2026 as against Rs 406.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
24-07-26 918.60 926.90 911.60 921.45 211503 15191 194417164.60 23767.45
23-07-26 934.25 938.25 915.00 918.55 281594 22053 260459398.75 23869.60
22-07-26 952.00 959.95 926.00 934.25 408514 30622 382409266.05 23996.25
21-07-26 953.30 965.10 948.25 961.90 316694 18783 303670505.20 24187.70
20-07-26 952.05 987.55 948.00 950.65 985701 47293 949655025.35 24238.50
17-07-26 968.50 968.50 940.10 945.00 338307 22005 321189793.30 24334.30
16-07-26 970.70 984.95 964.00 966.20 334009 24988 324605974.15 24072.75
15-07-26 974.50 977.85 964.05 969.75 265824 15774 257878165.50 24078.50
14-07-26 978.90 983.50 966.50 972.25 299826 18567 291508345.40 24052.05
13-07-26 984.05 988.95 962.00 979.95 572680 36532 559661199.85 24211.00
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

16492.44

PE Ratio

12.87

PB Ratio

1.93

Dividend Yield

0.54

ROE

28.63

ROCE

32.75

Book Value (₹)

477.507017

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 491761 0.27 491761 2
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 491761 0.27 491761 2
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 37756220 21.08 37756220 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50267145 28.07 50267145 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 88023365 49.14 88023365 20
Total ShareHolding for Promoter & Group 88515126 49.42 88515126 22
plus   Publice Share Holding
plus  Institution
Government(Central / State) 385 0.00 385 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25 0.00 25 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30426728 16.99 30426728 245
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6511814 3.64 6511814 15
Mutual Funds / UTI 3438241 1.92 3438241 24
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 117605 0.07 117605 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40494798 22.61 40494798 298
plus  Non Institution
Bodies Corporate 2737131 1.53 2734131 1015
Clearing Members 154 0.00 154 3
Directors & their Relatives 120223 0.07 120223 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3044119 1.70 3043619 10363
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1046252 0.58 1046152 3676
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5823745 3.25 5823745 17
Individuals holding nominal share capital up to Rs. 1 lakh 36107997 20.16 35781897 387621
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1752 0.00 1752 4
Others 862578 0.48 862578 2
Sub Total 50099946 27.97 49770246 402846
Total Public Shareholding 90594744 50.58 90265044 403144
Total of Promoter & Public ShareHolding 179109870 100.00 178780170 403166
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 179109870 100.00 178780170 403166

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales4,429.503,998.802,707.101,944.802,052.10
OPM (%)51.7341.8531.8410.4028.24
OP2,291.401,673.50861.90202.20579.60
Other Income354.50128.10104.6099.00103.60
PBIDT2,550.501,879.501,040.20362.50709.80
INTEREST23.9019.2014.5017.7013.30
PBDT2,526.601,860.301,025.70344.80696.50
PBT2,291.401,673.50861.90202.20579.60
EO0.000.000.000.000.00
PBT after EO2,291.401,673.50861.90202.20579.60
TAXES408.00285.20146.6032.20137.20
PAT1,885.401,388.30715.30170.00440.90
EPS105.2677.3439.189.3224.16
Raw Material12.1113.0717.5626.7018.17
Power and Fuel2.102.223.033.932.98
Employee Cost13.4213.1317.9822.8720.22
Other Manufacturing Expenses1.501.191.472.311.22
Selling and Administration Expenses12.5615.2814.6919.4014.99
Miscellaneous Expenses2.013.281.304.202.11
Revenue (Growth %) 10.7747.7239.20-5.237.16
PBIDT (Growth %)35.7080.69186.95-48.932.87
PAT (Growth %) 35.8194.09320.76-61.44-4.32
PBIDT (Margin %)57.5847.0038.4218.6434.59
PAT (Margin %) 42.5634.7226.428.7421.49

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 35.8035.8036.5036.5036.5036.40
Reserves Total 7298.105556.504665.504155.404054.603833.10
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds7333.905592.304702.004191.904091.103869.50
Secured Loans 181.80167.2074.90289.00128.40134.00
Unsecured Loans 92.80198.9086.20110.50128.00180.00
Total Debt274.60366.10161.10399.50256.40314.00
Other Liabilities70.2074.9087.0097.00100.7091.00
Total Liabilities7678.706033.304950.104688.404448.204274.50
APPLICATION OF FUNDS :
Gross Block 3783.703359.503157.102977.802678.302133.70
Less : Accumulated Depreciation 1216.901072.80923.30803.60672.40559.20
Less:Impairment of Assets50.000.000.000.000.000.00
Net Block 2516.802286.702233.802174.202005.901574.50
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress225.30133.9062.80128.70223.40517.80
Producing Properties0.000.000.000.000.000.00
Investments 855.10741.70657.50550.00337.00191.10
Current Assets, Loans & Advances
Inventories 642.10596.90616.00697.70769.20524.40
Sundry Debtors 1178.201076.60793.10575.60399.80536.70
Cash and Bank Balance1856.90864.90412.00100.90262.8054.10
Loans and Advances 720.80708.10533.70673.90694.601119.70
Total Current Assets4398.003246.502354.802048.102126.402234.90
Less : Current Liabilities and Provisions
Current Liabilities 435.50386.30383.60242.60250.20327.60
Provisions 155.70134.4025.3017.0012.8019.00
Total Current Liabilities & Provisions591.20520.70408.90259.60263.00346.60
Net Current Assets3806.802725.801945.901788.501863.401888.30
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets287.00215.80178.90127.600.000.00
Deferred Tax Liability246.00208.70207.80157.6041.3025.60
Net Deferred Tax41.007.10-28.90-30.00-41.30-25.60
Other Assets233.70138.1079.0077.0059.80128.40
Total Assets7678.706033.304950.104688.404448.204274.50
Contingent Liabilities3.000.4047.5037.902.701.10

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -183.1035.60-346.80-237.30-212.40
Investing Activities -3.20-92.50-436.60-960.50-1,443.90
Net Cash Flow -2.800.801.00-1.405.70
Operating Activities 183.5057.70784.401,196.401,662.00

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
VCN
V C Nannapaneni
Chairman / Executive Director / M D / Promoter
Executive
RN
Rajeev Nannapaneni
Vice Chairman & Chief Executive Officer
Executive
Independent Directors
ADM
A D Murthy Chavali
Independent Non Exe. Director
Ind.
VD
Vijayabhaskar Dronadula
Independent Non Exe. Director
Ind.
BL
B. Lakshminarayana
Independent Non Exe. Director
Ind.
KS
Kantipudi Suma
Independent Non Exe. Director
Ind.
NJ
Nitin Jain
Independent Non Exe. Director
Ind.
Other Officials
PP
PSRK Prasad
ED / EVP
Board
DLR
D Linga Rao
ED / President
Board
CVR
Chekuri Venkat Ramesh
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Natco Pharma Ltd? −

Natco Pharma Ltd trades on NSE under NATCOPHARM and on BSE under code 524816. The ISIN is INE987B01026 and the face value is Rs 2.

What is the share price of Natco Pharma Ltd today? +

As of 26 July 2026, Natco Pharma Ltd trades at Rs 921.45, a change of 2.90 (0.32%) on the day. Prices are live and subject to change.

What is the market capitalisation of Natco Pharma Ltd? +

As of 26 July 2026, Natco Pharma Ltd has a market cap of about Rs 16492.44 crore. This figure is live and moves with the share price.

Is Natco Pharma Ltd profitable? +

In March 2025, Natco Pharma Ltd reported a profit after tax of Rs 1,885.40 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Natco Pharma Ltd? +

: As of 26 July 2026, the PE (TTM) for Natco Pharma Ltd is 12.87 and the price-to-book ratio is 1.93. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Natco Pharma Ltd pay a dividend? +

As of 26 July 2026, the dividend yield for Natco Pharma Ltd is 0.54%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Natco Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 49.42% of Natco Pharma Ltd. Public shareholding is 50.58%, including mutual funds at 1.92% and foreign institutional investors at 16.99%.

What were the latest annual financials of Natco Pharma Ltd? +

In March 2025, Natco Pharma Ltd reported net sales of Rs 4,429.50 crore, revenue growth of 10.77%, and earnings per share of Rs 105.26.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web